Nealbarbital
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5-allyl-5-(1,1-dimethylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione | |
| Identifiers | |
| CAS Number |
561-83-1 |
| ATC code | none |
| PubChem | CID 521716 |
| ChemSpider |
455089 |
| UNII |
25ATP958PA |
| Synonyms | Nealbarbital, Censedal |
| Chemical data | |
| Formula | C12H18N2O3 |
| Molar mass | 238.28 g/mol |
| |
| |
| (verify) | |
Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s.[1] It has sedative and hypnotic effects, and was used for the treatment of insomnia.
References
- ↑ US Patent 2899435
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
